<?xml version="1.0" encoding="UTF-8"?>
<p id="par0030">We believe that TPE with a combination of 5% albumin and convalescent plasma replacement at the end of the procedure can be a valuable treatment option for COVID-19 patients and warrants a comparison trial with simple convalescent plasma infusion.</p>
